Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

Activism

Activist Investing Today: Brand Eyes Director Notice Compromises

By Ronald Orol
|
Published: September 12th, 2025
White & Case's Richard Brand suggests that passive investors, other institutions and academics should develop best practices for corporate bylaws seeking information about an activist's director nominations, as the matter right now is left to the courts to decide.
Activism

Activist Investing Today: Litt Targets REIT CEO Pay

By Ronald Orol
|
Published: July 3rd, 2025
Real estate activist Jonathan Litt discusses concerns that REIT boards often identify distorted peer groups to justify problematic executive pay, as well as why specific directors at 15 REITs should face vote-no campaigns.
Activism

Activist Investing Today: Skadden's Breheny on Expected SEC Shifts

By Ronald Orol
|
Published: June 13th, 2025
Brian Breheny, the former chief of the SEC's M&A division, discusses expected changes to regulations affecting activist investors, including why he thinks the nation's securities regulator can eliminate activist shareholder proposals.
Activism

Activist Investing Today: Eldar on Anti-Activist Pill Evolution

By Ronald Orol
|
Published: May 23rd, 2025
When corporations install anti-activist poison pills they're less likely to implement new share buybacks and their operationally focused capital expenditures tend to be higher, UC Berkeley School of Law professor Ofer Eldar explains.